Clara Alvarez Villalba, MD
Psychosomatic Medicine · Hallandale Beach, FLNPI 1497802839
Payments from drug & device makers
Across 156 payments — averaging $22.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Teva Pharmaceuticals USA, Inc.$571
- Otsuka America Pharmaceutical, Inc.$414
- Almatica Pharma LLC$261
- Sunovion Pharmaceuticals Inc.$217
- Johnson & Johnson$215
- plus $729 from 12 others
What the payments were for
- Food & beverage$3,11690%
- Education$33210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 57 | $1,041 |
| Teva Pharmaceuticals USA, Inc. | 21 | $571 |
| Otsuka America Pharmaceutical, Inc. | 15 | $414 |
| Almatica Pharma LLC | 13 | $261 |
| Sunovion Pharmaceuticals Inc. | 11 | $217 |
| Johnson & Johnson(2 entities) | 10 | $215 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $183 |
| Lundbeck LLC | 5 | $112 |
| Vanda Pharmaceuticals Inc. | 4 | $109 |
| Neurocrine Biosciences, Inc. | 5 | $108 |
| Jazz Pharmaceuticals Inc. | 2 | $46 |
| Alkermes, Inc. | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Biogen | 1 | $23 |
| Idorsia Pharmaceuticals US Inc | 1 | $23 |
| Neuronetics, Inc. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few psychosomatic medicine providers in Floridato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 29 | $730 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 12 | $534 |
| Alprazolam | 98 | $495 |
| Aripiprazole | 13 | $448 |
| Clonazepam | 86 | $429 |
| Olanzapine | 27 | $338 |
| Duloxetine Hcl | 12 | $259 |
| Mirtazapine | 11 | $230 |
| Zolpidem Tartrate | 26 | $217 |
| Bupropion XlBupropion Hcl | 16 | $215 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 18 | $157 |
| Trazodone Hcl | 26 | $137 |
| Gabapentin | 17 | $136 |
| Lorazepam | 35 | $107 |
| Fluoxetine Hcl | 20 | $105 |
Paid to pharmacies, not to this prescriber.
Other psychosomatic medicine in Hallandale Beach
- Mencia Gomez DevargasHollywood$288K
- Hortensa ValeronMiami$2K
- Nancy ChiarelloAtlantic Beach$135
- Laura CsereTampa$72
- Dominique MusselmanMiami$49
- Constanza Martinez PinanezMiami$17
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.